NAACCR Item #3852: HER2 ISH Dual Probe Ratio

Start Column


End Column




Padding Character

' '


Item # Length Source of Standard Year Implemented Version Implemented Year Retired Version Retired Column #
3852 4 NAACCR 2018 18 1762 - 1765

NAACCR XML: Tumor.her2IshDualProbeRatio

HER2 in situ hybridization (ISH) Dual Probe Ratio is the summary score for HER2 testing using a dual probe. The test will report results for both HER2 and CEP17, the latter used as a control. The HER2/CEP17 ratio is reported.
HER2 ISH Dual Probe Ratio is a Registry Data Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+.
0.0-99.9 Ratio of 0.0 to 99.9
XX.2 Less than 2.0
XX.3 Greater than or equal to 2.0
XX.7 Test ordered, results not in chart
XX.8 Not applicable: Information not collected for this case
(If this item is required by your standard setter, use of code XX.8 will result in an edit error.)
XX.9 Not documented in medical record
Results cannot be determined (indeterminate)
HER2 ISH Dual Probe Ratio not assessed or unknown if assessed
Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.